Search Results - "Børmer, O P"

Fecal calprotectin concentration in patients with colorectal carcinoma by Kristinsson, J, Røseth, A, Fagerhol, M K, Aadland, E, Schjønsby, H, Børmer, O P, Raknerud, N, Nygaard, K

“…The study contained herein was undertaken to investigate fecal calprotectin excretion in a series of patients with colorectal carcinoma and to determine…”
Get more information

Long-term renal function after treatment for malignant germ-cell tumours by FOSSA, S. D, AASS, N, WINDEREN, M, BÖRMER, O. P, OLSEN, D. R

“…To evaluate prospectively renal function in patients with malignant germ-cell tumours (MGCTs) >10 years after retroperitoneal lymph node dissection alone…”
Get full text

Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia by Paus, E, Nilsson, O, Børmer, O P, Fosså, S D, Otnes, B, Skovlund, E

“…Instability of prostate specific antigen (PSA) in serum might complicate the interpretation of the free-to-total PSA ratio. We studied the in vitro stability…”
Get more information

Automated albumin method underestimates pharmaceutical-grade albumin in vivo by BØRMER, O. P, AMLIE, L. M, PAUS, E, KONGSGARD, U

Get full text

Tumor markers in an evidence-based medicine by Bormer, Ole P.

Get full text

Epitope mapping and affinity estimation of 83 antibodies against prostate-specific antigen by Paus, E, Nustad, K, Børmer, O P

“…Eighty-three antibodies submitted to the ISOBM TD-3 Workshop on prostate-specific antigen (PSA) were characterized by cross-inhibition studies, immunometric…”
Get more information

Specificity and affinity of 30 monoclonal antibodies against alpha-fetoprotein by Nustad, K, Paus, E, Kierulf, B, Børmer, O P

“…Twenty-two antibodies with high affinity for AFP could be classified into groups according to five AFP binding regions, designated A-E, based on…”
Get more information

Immunoassays for carcinoembryonic antigen: specificity and interferences by Børmer, O P

Get more information

Circulating secretory component in relation to early diagnosis and treatment of liver metastasis from colorectal carcinomas by Kvale, D, Norstein, J, Meling, G I, Børmer, O P, Brandtzaeg, P, Langmark, F, Rognum, T O

“…AIMS: To evaluate serum secretory component in relation to early detection and clinical management of liver metastasis in patients with colorectal cancer…”
Get full text

Evaluation of serum CA 125 levels in the monitoring of ovarian cancer by Vergote, I B, Børmer, O P, Abeler, V M

“…Serum CA 125 levels were evaluated in 227 patients with ovarian cancer. CA 125 levels were elevated in 86% of the patients. All histologic types, including…”
Get more information

From tissue polypeptide antigen to specific cytokeratin assays by Børmer, O P

Get more information

Immunohistochemical characterization of 22 monoclonal antibodies against the CA125 antigen: 2nd report from the ISOBM TD-1 Workshop by Nap, M, Vitali, A, Nustad, K, Bast, Jr, R C, O'Brien, T J, Nilsson, O, Seguin, P, Suresh, M R, Børmer, O P, Saga, T, de Bruijn, H W, Nozawa, S, Kreutz, F T, Jette, D, Sakahara, H, Gadnell, M, Endo, K, Barlow, E H, Warren, D, Paus, E, Hammarström, S, Kenemans, P, Hilgers, J

“…We evaluated the immunohistological (IH) characteristics of 22 different antibodies that were submitted for study in the frame of the TD-1 ISOBM Workshop on…”
Get more information

Serum CA 125 level allows early identification of nonresponders during induction chemotherapy by Makar, A P, Kristensen, G B, Børmer, O P, Tropé, C G

“…CA 125 was measured during induction chemotherapy in 119 patients with advanced epithelial ovarian cancer who had residual disease after primary surgery in…”
Get more information

Is serum CA 125 at the time of relapse a prognostic indicator for further survival prognosis in patients with ovarian cancer? by Makar, A P, Kristensen, G B, Børmer, O P, Tropé, C G

“…The prognostic significance of serum CA 125 level before treatment of relapse for invasive epithelial ovarian cancer has been evaluated in 135 patients. At…”
Get more information

CA125 in peritoneal fluid of ovarian cancer patients by Vergote, I B, Onsrud, M, Børmer, O P, Sert, B M, Moen, M

“…The presence of CA125 was assessed in peritoneal fluid from 70 patients with ovarian cancer and 32 control patients. The follow-up period ranged from 39 to 89…”
Get more information

Purification of a cytotoxic factor from human and rat tissues by Bormer, O P

“…Human and rat normal tissues and tumours have been studied for the presence of toxic substances, possibly of importance in the development of cachexia in…”
Get full text

Carcinoembryonic antigen in anal carcinoma by Tanum, G, Stenwig, A E, Børmer, O P, Tveit, K M

“…Patients with squamous cell carcinoma of the anal canal occasionally present with an elevated level of carcinoembryonic antigen (CEA) in serum. The present…”
Get more information

Protein epitopes in carcinoembryonic antigen. Report of the ISOBM TD8 workshop by Bjerner, J, Lebedin, Y, Bellanger, L, Kuroki, M, Shively, J E, Varaas, T, Nustad, K, Hammarström, S, Børmer, O P

“…To characterize antigenic sites in carcinoembryonic antigen (CEA) further and to investigate whether there are differences between colon tumor CEA and meconium…”
Get more information

Prognostic value of pre- and postoperative serum CA 125 levels in ovarian cancer: new aspects and multivariate analysis by Makar, A P, Kristensen, G B, Kaern, J, Børmer, O P, Abeler, V M, Tropé, C G

“…The prognostic significance of the serum CA 125 level was studied in 687 patients with invasive epithelial ovarian malignancies. The samples were collected…”
Get more information

Summary report of the TD-3 workshop: characterization of 83 antibodies against prostate-specific antigen by Stenman, U H, Paus, E, Allard, W J, Andersson, I, Andrès, C, Barnett, T R, Becker, C, Belenky, A, Bellanger, L, Pellegrino, C M, Børmer, O P, Davis, G, Dowell, B, Grauer, L S, Jette, D C, Karlsson, B, Kreutz, F T, van der Kwast, T M, Lauren, L, Leinimaa, M, Leinonen, J, Lilja, H, Linton, H J, Nap, M, Hilgers, J

“…Twelve research groups participated in the ISOBM TD-3 Workshop in which the reactivity and specificity of 83 antibodies against prostate-specific antigen (PSA)…”
Get more information